The added value of contrast-enhanced spectral mammography for the assessment of symptomatic breast cancer patients

Share :
Published: 27 Jan 2020
Views: 677
Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain

Dr Rodrigo Alcantra speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the benefits of contrast-enhanced spectral mammography.

He explains the added value of using this technique for patients who are symptomatic, which allows the identification of multifocal lesions in the first assessment.